How Nanoparticles Help in Combating Chronic Wound Biofilms Infection?
Gang Jing,Chen Hu,Keyi Fang,Yingying Li,Linlin Wang
DOI: https://doi.org/10.2147/ijn.s484473
IF: 7.033
2024-11-20
International Journal of Nanomedicine
Abstract:Gang Jing, 1, &ast Chen Hu, 2, &ast Keyi Fang, 3 Yingying Li, 3 Linlin Wang 1 1 Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, People's Republic of China; 2 Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, People's Republic of China; 3 School of Stomatology, Hainan Medical University, Haikou, Hainan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Linlin Wang, Hainan General Hospital, Hainan Affiliated Hospital of Hainan medical University, No. 19 Xiuhua Avenue, Haikou, Hainan, 570311, People's Republic of China, Email Chronic wound infection has become a global health problem, with bacterial biofilms, which are difficult to penetrate using traditional antibiotics, considered the primary cause of recurrent infection and delayed healing in chronic wounds. In recent years, the outstanding performance of nanomaterials in controlling biofilm infections has been widely acknowledged, and these materials are regarded as highly promising for chronic wound infection management. The formation and structure of chronic wound biofilms undergo complex dynamic changes. Therefore, a deep understanding of the underlying causes of repeated wound infections and the specific antibacterial mechanisms of nanomaterials at different stages of biofilm formation is crucial for effective "chronic wound infection management". This review first reveals the relationship between biofilms, wound chronicity, and recurrent infections. Secondly, it focuses on the four stages of chronic wound biofilm formation: (1) adhesion stage, (2) aggregation and promotion stage, (3) maturation stage, and (4) regeneration and dissemination stage. It also comprehensively summarizes the specific antibacterial mechanisms of nanomaterials. This study analyzes essential factors affecting the control of chronic wound biofilms by nanoparticles from various perspectives, such as the material itself, the local wound environment, and the systemic host response. Finally, the limitations and potential future trends in current research are discussed. In summary, nanoparticles represent a promising strategy for combating chronic wound biofilm infections, and this review provides new insights for alternative adjuvant therapies in managing bacterial biofilm infections in chronic wounds. Keywords: bacteria, nanomaterials, mechanism, wound management Graphical With the acceleration of aging in the global population, chronic wounds have become a significant public health threat and healthcare burden. A positive correlation was observed between the age of patients and the healing period of chronic wounds. 1 Bacterial infection is the most common complication of chronic wounds, and most bacteria in chronic wounds occur as biofilm, which is a leading cause of delayed wound healing. 2 Significant types of chronic wounds include diabetic ulcers, traumatic ulcers, pressure ulcers, and venous ulcers. Chronic non-healing wounds often deteriorate into multidrug-resistant (MDR) bacterial infections, producing a large amount of purulent discharge with malodor, presenting an urgent problem that requires clinical treatment. The traditional treatment for bacterial biofilm removal in chronic wounds involves antibiotic therapies. Currently, studies have shown that the overuse of antibiotics significantly promotes the emergence of "multidrug-resistant bacteria", which not only increases treatment costs but also can raise case fatality rates. The distribution of drug-resistant pathogens was identified as a significant global public health problem. Nanoparticles have been reported to exhibit high antimicrobial activity against "multidrug-resistant bacteria", and due to multiple mechanisms acting simultaneously, it is difficult for new drug-resistant strains to emerge. 3 Recent microbiological research has begun to focus on antibacterial nanoparticles, whose effectiveness in killing various pathogens in wounds, such as bacteria, fungi, and viruses, has been demonstrated in many laboratory studies. 4 Recent studies have elucidated the mechanisms and advantages of nanoparticles in inhibiting bacterial growth and biofilm formation by comparing various types of nanomaterials—such as metal and polymer nanoparticles—regarding their antimicrobial properties. 3 In addition, researchers have categorized these nanoparticles into four main types, each employing different mechanisms against biofilms. These mechanisms include the direct killing of bacteria within the biofilm, disruption of the biofilm's structure, release of antimicrobial agents, and enhancement of i -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology